Amgen

FDA Approval of Mirati Lung Cancer Drug Sets Stage for Competition With Amgen
MedCity News
Wed, 12/14/22 - 10:19 am
Amgen
Mirati Therapeutics
Krazati
Lumakras
FDA
lung cancer
Amgen to Buy Horizon in Biotech’s Biggest Deal of 2022
BioSpace
Mon, 12/12/22 - 10:34 am
Amgen
Horizon Therapeutics
M&A
Could Amgen's Heart Disease Candidate Generate Billions in Sales?
Motley Fool
Sun, 12/11/22 - 01:26 pm
Amgen
heart disease
olpasiran
Senate Finance chair goes after Amgen again on US taxes, asking for payment specifics
Endpoints
Thu, 12/8/22 - 11:25 pm
Senate
taxes
Amgen
Amgen to push latecomer obesity drug into midstage testing
Pharmaphorum
Sun, 12/4/22 - 01:26 pm
Amgen
Novo Nordisk
Eli Lilly
obesity
clinical trials
AMG 133
With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker
Fierce Pharma
Fri, 12/2/22 - 11:13 am
Horizon Therapeutics
Sanofi
Amgen
M&A
J&J sues Amgen over plan to sell drug similar to Stelara
Business Insurance
Thu, 12/1/22 - 10:48 am
JNJ
Janssen
Amgen
legal
ulcerative colitis
patents
Stelara
Large pharmas probe takeover of Horizon Therapeutics
BioPharma Dive
Wed, 11/30/22 - 10:58 am
Horizon Pharma
M&A
JNJ
Sanofi
Amgen
Mirati is once again the subject of Big Pharma takeover talks: report
Fierce Biotech
Sun, 11/27/22 - 07:08 pm
Mirati Therapeutics
M&A
Amgen
Lumakras
Best Places to Work in Biopharma 2023 Report Reveals Most Sought-After Employers
BioSpace
Mon, 11/14/22 - 10:59 am
biotech
biopharma
employers
corporate culture
Moderna Therapeutics
Genentech
Pfizer
Amgen
AbbVie
Arrowhead Gets $250M in Royalty Deal for Cardio Drug Heading to Phase 3
MedCity News
Wed, 11/9/22 - 11:30 pm
Amgen
Arrowhead Pharmaceuticals
olpasiran
heart disease
Early data hint at benefit for Amgen’s obesity drug
BioPharma Dive
Wed, 11/9/22 - 10:32 am
Amgen
obesity
Eli Lilly
Novo Nordisk
AMG 133
Amgen to test new way to lower heart risk with large drug trial
BioPharma Dive
Mon, 11/7/22 - 11:00 am
Amgen
clinical trials
heart disease
olpasiran
Amgen's Supreme Court bid answered in long-running Repatha patent feud against Sanofi, Regeneron
Fierce Pharma
Mon, 11/7/22 - 10:55 am
Amgen
Repatha
patents
Supreme Court
Sanofi
Regeneron
What Pharma Companies Can Expect From the Influx of Humira Biosimilars
Drug Channels
Fri, 10/14/22 - 10:15 am
AbbVie
Humira
biosimilars
Amgen
Amjevita
Amgen study: Biosimilars saved the healthcare system $21B
Medical Marketing and Media
Wed, 10/12/22 - 11:38 pm
Amgen
biosimilars
Why Amgen Is Up More Than 6% Today
Motley Fool
Tue, 10/11/22 - 04:05 pm
Amgen
AMG133
obesity
R&D acceleration: Amgen opens its second largest research site, with lab and office space for 650 staff
Endpoints
Fri, 10/7/22 - 11:02 am
Amgen
R&D
SITC 2022 preview – cytokines and oral checkpoints
EP Vantage
Thu, 10/6/22 - 10:39 am
SITC
Incyte
ChemoCentryx
Amgen
cytokines
No big bang for biopharma buyouts
EP Vantage
Wed, 10/5/22 - 10:29 am
M&A
Pfizer
Global Blood Therapeutics
Amgen
ChemoCentryx
Novo Nordisk
Forma
Alcon
Aerie Pharmaceuticals
Gilead Sciences
MiroBio

Pages